👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
✓ Verified
Trust score 98/100
Accepting new patients
Dr
Dr Hamoun Rozati
Oncology
English
Persian
10,327+
Patients seen
9
Years in practice
9
Publications
2
Languages spoken
About
Dr Hamoun Rozati is a Consultant in Clinical Oncology specialising in the management of prostate cancer and brain tumours. He provides care for patients across London and Essex and is based at St Bartholomew's Hospital, where he leads the stereotactic radiosurgery service and maintains an active NHS clinical practice.
His clinical work includes the treatment of early and advanced prostate cancer, primary and metastatic brain tumours, and selected benign intracranial conditions such as meningiomas and vestibular schwannomas. He has specific expertise in stereotactic radiosurgery and advanced radiotherapy techniques, alongside the use of evidence-based systemic therapies including hormone therapy, targeted treatments, and immunotherapy.
Dr Rozati completed specialist oncology training through the UK Oncology Recruitment Programme, where he was ranked first nationally. His training included appointments at The Royal Marsden Hospital and University College Hospital. He holds a postgraduate research degree from Imperial College London and a Master’s degree from the Institute of Cancer Research.
In addition to his clinical work, Dr Rozati is involved in clinical research and medical education. He leads clinical trials, publishes in peer-reviewed journals, speaks at international conferences, and serves as Head of Clinical Oncology Training at Barts Health NHS Trust.
His clinical work includes the treatment of early and advanced prostate cancer, primary and metastatic brain tumours, and selected benign intracranial conditions such as meningiomas and vestibular schwannomas. He has specific expertise in stereotactic radiosurgery and advanced radiotherapy techniques, alongside the use of evidence-based systemic therapies including hormone therapy, targeted treatments, and immunotherapy.
Dr Rozati completed specialist oncology training through the UK Oncology Recruitment Programme, where he was ranked first nationally. His training included appointments at The Royal Marsden Hospital and University College Hospital. He holds a postgraduate research degree from Imperial College London and a Master’s degree from the Institute of Cancer Research.
In addition to his clinical work, Dr Rozati is involved in clinical research and medical education. He leads clinical trials, publishes in peer-reviewed journals, speaks at international conferences, and serves as Head of Clinical Oncology Training at Barts Health NHS Trust.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Hamoun Rozati
Education & training
-
2007–2013 MD · Medicine and Surgery
-
2013–2017 Residency · Oncology
Career & appointments
-
2017-09–2018-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
Allianz Professional · 2,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 1,683 |
| Annual physical exam | 99395 | 2,373 |
| Vaccination administration | 90471 | 893 |
| Minor procedure (skin) | 17110 | 2,730 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 90 min | in_clinic | 720.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 6 · i10: 2
-
Validation of clinical scoring in Oncology
DOI: 10.7648/euroclin.2026.0 · PMID: 32070305 · cited by 59
-
Long-term follow-up of Oncology across GB
DOI: 10.3000/euroclin.2025.1 · PMID: 31913068 · cited by 161
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
Society memberships
- WONCA Europe — Family Doctors — Member · since 2018
- national college of family doctors — Member · since 2018
- European Union of Medical Specialists (UEMS) — Member · since 2018
Patient reviews
- Bedside Manner
- 5.00
- Knowledge
- 5.00
- Wait Time
- 4.75
- Staff Friendliness
- 5.00
- Ease Of Appointment
- 4.90
- Value For Money
- 4.92
- Would Recommend Pct
- 99
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · hamoun.rozati@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
